Another commonality between in vitro and in vivo findings was the upregulation of DNMT3A after treatment with nimesulide both in the patient sample and in the OCI3-AML cell line (Figure 1D and Supplementary Figure 5). This evidence concerns the gene DNMT3A and acute myeloid leukemia.